The CYP polymorphisms that we studied included CYP1A1 I462V and CYP1A1 T461N, as well as CYPIA2 D348N, CYP1A2 I386F, and CYP1A2 C406Y; the CYP1A1 polymorphisms were studied because their incidence is linked to lung, breast, and endometrial cancer [113]. Here, CYP1A1 is linked to endometrial cancer.